Clinical Trial Update: A Multicenter, Open-Label Trial to Evaluate the Safety and Efficacy of the Sufentanil Sublingual Tablet 30 mcg in Patients With Post-Operative Pain [Phase 3]

View source ↗

Summary

A multicenter, open-label Phase 3 trial evaluated the safety and efficacy of a 30 mcg sufentanil sublingual tablet for postoperative pain; the study completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Sufentanil Sublingual Tablet 30 mcg (sufentanil)

Snippet

Sponsor: Talphera, Inc | Conditions: Acute Moderate-to-severe Pain | Phase 3 | Status: COMPLETED | Results posted: 2017-03-15